DNA-based vaccine treatment for colorectal cancer to undergo first human study

(Digestive Disease Week) Combining a DNA vaccine, which boosts the body's immune response against tumors, with an antibody that blocks the body's natural defense against the potency of the DNA vaccine, may lead to the development of an effective treatment for late stage colorectal cancer, when a cure is not often possible. Preliminary research leading up to this trial will be presented at Digestive Disease Week ® 2018.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news